Recent Posts
- Optimizing Exercise Interventions for Overweight and Obese Patients with Type 2 Diabetes Mellitus: A Network Meta-Analysis
- Obesity-Driven Phosphatidylethanolamine Dysregulation: A Crucial Link to Alzheimer’s Disease Progression
- Differential Impact of Metabolic Bariatric Surgery Versus Semaglutide on Hepatic and Extrahepatic Outcomes in MASLD and Type 2 Diabetes
- Transforming Obesity Care: Meal Replacement Intervention in a Multi-Ethnic High-Risk Population
- Semaglutide Treatment in Type 2 Diabetes: Unveiling Its Impact on Liver Cirrhosis and Hepatocellular Carcinoma
CME/CPD Provider Number: CPDSO 50212
